nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—ABCB1—Lisinopril—systemic scleroderma	0.158	0.272	CbGbCtD
Tolvaptan—ABCB1—Captopril—systemic scleroderma	0.118	0.203	CbGbCtD
Tolvaptan—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.093	0.16	CbGbCtD
Tolvaptan—ABCB1—Prednisone—systemic scleroderma	0.0744	0.128	CbGbCtD
Tolvaptan—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0557	0.0959	CbGbCtD
Tolvaptan—CYP3A4—Prednisone—systemic scleroderma	0.0446	0.0767	CbGbCtD
Tolvaptan—ABCB1—Methotrexate—systemic scleroderma	0.0373	0.0642	CbGbCtD
Tolvaptan—Dehydration—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00315	CcSEcCtD
Tolvaptan—Dry mouth—Mometasone—systemic scleroderma	0.00131	0.00312	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Mycophenolate mofetil—systemic scleroderma	0.0013	0.00309	CcSEcCtD
Tolvaptan—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00129	0.00308	CcSEcCtD
Tolvaptan—Urinary tract disorder—Leflunomide—systemic scleroderma	0.00129	0.00307	CcSEcCtD
Tolvaptan—Connective tissue disorder—Leflunomide—systemic scleroderma	0.00128	0.00306	CcSEcCtD
Tolvaptan—Anaphylactic shock—Mometasone—systemic scleroderma	0.00128	0.00306	CcSEcCtD
Tolvaptan—Urethral disorder—Leflunomide—systemic scleroderma	0.00128	0.00305	CcSEcCtD
Tolvaptan—Ill-defined disorder—Captopril—systemic scleroderma	0.00128	0.00305	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00305	CcSEcCtD
Tolvaptan—Constipation—Pentoxifylline—systemic scleroderma	0.00127	0.00303	CcSEcCtD
Tolvaptan—Hyperglycaemia—Lisinopril—systemic scleroderma	0.00126	0.00301	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00299	CcSEcCtD
Tolvaptan—Immune system disorder—Azathioprine—systemic scleroderma	0.00125	0.00298	CcSEcCtD
Tolvaptan—Mediastinal disorder—Azathioprine—systemic scleroderma	0.00124	0.00297	CcSEcCtD
Tolvaptan—Malaise—Captopril—systemic scleroderma	0.00124	0.00297	CcSEcCtD
Tolvaptan—Syncope—Captopril—systemic scleroderma	0.00124	0.00295	CcSEcCtD
Tolvaptan—Urinary tract disorder—Mycophenolic acid—systemic scleroderma	0.00123	0.00293	CcSEcCtD
Tolvaptan—Renal failure—Lisinopril—systemic scleroderma	0.00123	0.00293	CcSEcCtD
Tolvaptan—Connective tissue disorder—Mycophenolic acid—systemic scleroderma	0.00122	0.00292	CcSEcCtD
Tolvaptan—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00122	0.00292	CcSEcCtD
Tolvaptan—Anorexia—Mometasone—systemic scleroderma	0.00122	0.00291	CcSEcCtD
Tolvaptan—Urethral disorder—Mycophenolic acid—systemic scleroderma	0.00122	0.00291	CcSEcCtD
Tolvaptan—Loss of consciousness—Captopril—systemic scleroderma	0.00121	0.00289	CcSEcCtD
Tolvaptan—Cardiac disorder—Leflunomide—systemic scleroderma	0.00121	0.00289	CcSEcCtD
Tolvaptan—Ecchymosis—Prednisone—systemic scleroderma	0.0012	0.00286	CcSEcCtD
Tolvaptan—Hyperuricaemia—Methotrexate—systemic scleroderma	0.00119	0.00285	CcSEcCtD
Tolvaptan—Immune system disorder—Leflunomide—systemic scleroderma	0.00118	0.00281	CcSEcCtD
Tolvaptan—Mediastinal disorder—Leflunomide—systemic scleroderma	0.00118	0.00281	CcSEcCtD
Tolvaptan—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00117	0.0028	CcSEcCtD
Tolvaptan—Discomfort—Captopril—systemic scleroderma	0.00116	0.00277	CcSEcCtD
Tolvaptan—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.00115	0.00276	CcSEcCtD
Tolvaptan—Dry mouth—Captopril—systemic scleroderma	0.00115	0.00274	CcSEcCtD
Tolvaptan—Malnutrition—Leflunomide—systemic scleroderma	0.00114	0.00271	CcSEcCtD
Tolvaptan—Pollakiuria—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00271	CcSEcCtD
Tolvaptan—Angiopathy—Mycophenolic acid—systemic scleroderma	0.00113	0.00269	CcSEcCtD
Tolvaptan—Blood uric acid increased—Methotrexate—systemic scleroderma	0.00113	0.00269	CcSEcCtD
Tolvaptan—Respiratory failure—Methotrexate—systemic scleroderma	0.00113	0.00269	CcSEcCtD
Tolvaptan—Anaphylactic shock—Captopril—systemic scleroderma	0.00112	0.00268	CcSEcCtD
Tolvaptan—Mediastinal disorder—Mycophenolic acid—systemic scleroderma	0.00112	0.00268	CcSEcCtD
Tolvaptan—Ill-defined disorder—Azathioprine—systemic scleroderma	0.00112	0.00266	CcSEcCtD
Tolvaptan—Decreased appetite—Mometasone—systemic scleroderma	0.00111	0.00266	CcSEcCtD
Tolvaptan—Dysgeusia—Leflunomide—systemic scleroderma	0.00111	0.00265	CcSEcCtD
Tolvaptan—Pulmonary embolism—Methotrexate—systemic scleroderma	0.00111	0.00264	CcSEcCtD
Tolvaptan—Urinary tract disorder—Lisinopril—systemic scleroderma	0.00111	0.00264	CcSEcCtD
Tolvaptan—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00264	CcSEcCtD
Tolvaptan—Shock—Captopril—systemic scleroderma	0.00111	0.00264	CcSEcCtD
Tolvaptan—Urethral disorder—Lisinopril—systemic scleroderma	0.0011	0.00262	CcSEcCtD
Tolvaptan—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00109	0.00261	CcSEcCtD
Tolvaptan—Malaise—Azathioprine—systemic scleroderma	0.00108	0.00259	CcSEcCtD
Tolvaptan—Malnutrition—Mycophenolic acid—systemic scleroderma	0.00108	0.00259	CcSEcCtD
Tolvaptan—Renal failure—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00257	CcSEcCtD
Tolvaptan—Anorexia—Captopril—systemic scleroderma	0.00107	0.00256	CcSEcCtD
Tolvaptan—Asthenia—Pentoxifylline—systemic scleroderma	0.00106	0.00254	CcSEcCtD
Tolvaptan—Ill-defined disorder—Leflunomide—systemic scleroderma	0.00105	0.00251	CcSEcCtD
Tolvaptan—Pruritus—Pentoxifylline—systemic scleroderma	0.00105	0.00251	CcSEcCtD
Tolvaptan—Malaise—Leflunomide—systemic scleroderma	0.00102	0.00244	CcSEcCtD
Tolvaptan—Angiopathy—Lisinopril—systemic scleroderma	0.00102	0.00243	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00102	0.00243	CcSEcCtD
Tolvaptan—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00102	0.00242	CcSEcCtD
Tolvaptan—Body temperature increased—Mometasone—systemic scleroderma	0.00101	0.00242	CcSEcCtD
Tolvaptan—Discomfort—Azathioprine—systemic scleroderma	0.00101	0.00241	CcSEcCtD
Tolvaptan—Mediastinal disorder—Lisinopril—systemic scleroderma	0.00101	0.00241	CcSEcCtD
Tolvaptan—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.00101	0.0024	CcSEcCtD
Tolvaptan—Ecchymosis—Methotrexate—systemic scleroderma	0.001	0.00239	CcSEcCtD
Tolvaptan—Urine output increased—Methotrexate—systemic scleroderma	0.001	0.00239	CcSEcCtD
Tolvaptan—Dizziness—Pentoxifylline—systemic scleroderma	0.000981	0.00234	CcSEcCtD
Tolvaptan—Decreased appetite—Captopril—systemic scleroderma	0.000977	0.00233	CcSEcCtD
Tolvaptan—Malaise—Mycophenolic acid—systemic scleroderma	0.000977	0.00233	CcSEcCtD
Tolvaptan—Malnutrition—Lisinopril—systemic scleroderma	0.000976	0.00233	CcSEcCtD
Tolvaptan—Syncope—Mycophenolic acid—systemic scleroderma	0.000971	0.00232	CcSEcCtD
Tolvaptan—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.00097	0.00231	CcSEcCtD
Tolvaptan—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.000965	0.0023	CcSEcCtD
Tolvaptan—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.000963	0.0023	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.000962	0.0023	CcSEcCtD
Tolvaptan—Constipation—Captopril—systemic scleroderma	0.000962	0.00229	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00096	0.00229	CcSEcCtD
Tolvaptan—Dysgeusia—Lisinopril—systemic scleroderma	0.000955	0.00228	CcSEcCtD
Tolvaptan—Discomfort—Leflunomide—systemic scleroderma	0.000955	0.00228	CcSEcCtD
Tolvaptan—Skin disorder—Azathioprine—systemic scleroderma	0.000953	0.00227	CcSEcCtD
Tolvaptan—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000952	0.00227	CcSEcCtD
Tolvaptan—Dry mouth—Leflunomide—systemic scleroderma	0.000945	0.00226	CcSEcCtD
Tolvaptan—Headache—Pentoxifylline—systemic scleroderma	0.000929	0.00222	CcSEcCtD
Tolvaptan—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000927	0.00221	CcSEcCtD
Tolvaptan—Feeling abnormal—Captopril—systemic scleroderma	0.000927	0.00221	CcSEcCtD
Tolvaptan—Asthenia—Mometasone—systemic scleroderma	0.000919	0.00219	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000916	0.00219	CcSEcCtD
Tolvaptan—Polyuria—Methotrexate—systemic scleroderma	0.000916	0.00219	CcSEcCtD
Tolvaptan—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000911	0.00218	CcSEcCtD
Tolvaptan—Discomfort—Mycophenolic acid—systemic scleroderma	0.000911	0.00217	CcSEcCtD
Tolvaptan—Nervous system disorder—Leflunomide—systemic scleroderma	0.000909	0.00217	CcSEcCtD
Tolvaptan—Pruritus—Mometasone—systemic scleroderma	0.000906	0.00216	CcSEcCtD
Tolvaptan—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000905	0.00216	CcSEcCtD
Tolvaptan—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000902	0.00215	CcSEcCtD
Tolvaptan—Skin disorder—Leflunomide—systemic scleroderma	0.0009	0.00215	CcSEcCtD
Tolvaptan—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000891	0.00213	CcSEcCtD
Tolvaptan—Body temperature increased—Captopril—systemic scleroderma	0.000889	0.00212	CcSEcCtD
Tolvaptan—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000885	0.00211	CcSEcCtD
Tolvaptan—Anorexia—Leflunomide—systemic scleroderma	0.000883	0.00211	CcSEcCtD
Tolvaptan—Nausea—Pentoxifylline—systemic scleroderma	0.000881	0.0021	CcSEcCtD
Tolvaptan—Malaise—Lisinopril—systemic scleroderma	0.00088	0.0021	CcSEcCtD
Tolvaptan—Diarrhoea—Mometasone—systemic scleroderma	0.000876	0.00209	CcSEcCtD
Tolvaptan—Syncope—Lisinopril—systemic scleroderma	0.000875	0.00209	CcSEcCtD
Tolvaptan—Shock—Mycophenolic acid—systemic scleroderma	0.00087	0.00208	CcSEcCtD
Tolvaptan—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000867	0.00207	CcSEcCtD
Tolvaptan—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000859	0.00205	CcSEcCtD
Tolvaptan—Loss of consciousness—Lisinopril—systemic scleroderma	0.000858	0.00205	CcSEcCtD
Tolvaptan—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000855	0.00204	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000849	0.00203	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000847	0.00202	CcSEcCtD
Tolvaptan—Anorexia—Mycophenolic acid—systemic scleroderma	0.000843	0.00201	CcSEcCtD
Tolvaptan—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000837	0.002	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000825	0.00197	CcSEcCtD
Tolvaptan—Discomfort—Lisinopril—systemic scleroderma	0.000821	0.00196	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000821	0.00196	CcSEcCtD
Tolvaptan—Dry mouth—Lisinopril—systemic scleroderma	0.000812	0.00194	CcSEcCtD
Tolvaptan—Feeling abnormal—Azathioprine—systemic scleroderma	0.000809	0.00193	CcSEcCtD
Tolvaptan—Asthenia—Captopril—systemic scleroderma	0.000807	0.00193	CcSEcCtD
Tolvaptan—Decreased appetite—Leflunomide—systemic scleroderma	0.000806	0.00192	CcSEcCtD
Tolvaptan—Headache—Mometasone—systemic scleroderma	0.000802	0.00191	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.0008	0.00191	CcSEcCtD
Tolvaptan—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000796	0.0019	CcSEcCtD
Tolvaptan—Pruritus—Captopril—systemic scleroderma	0.000796	0.0019	CcSEcCtD
Tolvaptan—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000793	0.00189	CcSEcCtD
Tolvaptan—Constipation—Leflunomide—systemic scleroderma	0.000793	0.00189	CcSEcCtD
Tolvaptan—Shock—Lisinopril—systemic scleroderma	0.000783	0.00187	CcSEcCtD
Tolvaptan—Body temperature increased—Azathioprine—systemic scleroderma	0.000776	0.00185	CcSEcCtD
Tolvaptan—Skin disorder—Lisinopril—systemic scleroderma	0.000773	0.00185	CcSEcCtD
Tolvaptan—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000771	0.00184	CcSEcCtD
Tolvaptan—Diarrhoea—Captopril—systemic scleroderma	0.000769	0.00184	CcSEcCtD
Tolvaptan—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000769	0.00183	CcSEcCtD
Tolvaptan—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000767	0.00183	CcSEcCtD
Tolvaptan—Feeling abnormal—Leflunomide—systemic scleroderma	0.000764	0.00182	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000763	0.00182	CcSEcCtD
Tolvaptan—Nausea—Mometasone—systemic scleroderma	0.00076	0.00181	CcSEcCtD
Tolvaptan—Anorexia—Lisinopril—systemic scleroderma	0.000759	0.00181	CcSEcCtD
Tolvaptan—Constipation—Mycophenolic acid—systemic scleroderma	0.000756	0.0018	CcSEcCtD
Tolvaptan—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000751	0.00179	CcSEcCtD
Tolvaptan—Hyperglycaemia—Prednisone—systemic scleroderma	0.00075	0.00179	CcSEcCtD
Tolvaptan—Dizziness—Captopril—systemic scleroderma	0.000744	0.00177	CcSEcCtD
Tolvaptan—Body temperature increased—Leflunomide—systemic scleroderma	0.000733	0.00175	CcSEcCtD
Tolvaptan—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000729	0.00174	CcSEcCtD
Tolvaptan—Breast disorder—Methotrexate—systemic scleroderma	0.000727	0.00173	CcSEcCtD
Tolvaptan—Hypersensitivity—Azathioprine—systemic scleroderma	0.000723	0.00173	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000723	0.00173	CcSEcCtD
Tolvaptan—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000719	0.00172	CcSEcCtD
Tolvaptan—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000712	0.0017	CcSEcCtD
Tolvaptan—Headache—Captopril—systemic scleroderma	0.000704	0.00168	CcSEcCtD
Tolvaptan—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000699	0.00167	CcSEcCtD
Tolvaptan—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000698	0.00167	CcSEcCtD
Tolvaptan—Decreased appetite—Lisinopril—systemic scleroderma	0.000692	0.00165	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000687	0.00164	CcSEcCtD
Tolvaptan—Shock—Mycophenolate mofetil—systemic scleroderma	0.000686	0.00164	CcSEcCtD
Tolvaptan—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000684	0.00163	CcSEcCtD
Tolvaptan—Hypersensitivity—Leflunomide—systemic scleroderma	0.000683	0.00163	CcSEcCtD
Tolvaptan—Constipation—Lisinopril—systemic scleroderma	0.000681	0.00163	CcSEcCtD
Tolvaptan—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000678	0.00162	CcSEcCtD
Tolvaptan—Diarrhoea—Azathioprine—systemic scleroderma	0.000671	0.0016	CcSEcCtD
Tolvaptan—Nausea—Captopril—systemic scleroderma	0.000668	0.00159	CcSEcCtD
Tolvaptan—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000665	0.00159	CcSEcCtD
Tolvaptan—Asthenia—Leflunomide—systemic scleroderma	0.000665	0.00159	CcSEcCtD
Tolvaptan—Feeling abnormal—Lisinopril—systemic scleroderma	0.000656	0.00157	CcSEcCtD
Tolvaptan—Pruritus—Leflunomide—systemic scleroderma	0.000656	0.00156	CcSEcCtD
Tolvaptan—Connective tissue disorder—Prednisone—systemic scleroderma	0.000654	0.00156	CcSEcCtD
Tolvaptan—Dizziness—Azathioprine—systemic scleroderma	0.000649	0.00155	CcSEcCtD
Tolvaptan—Asthenia—Mycophenolic acid—systemic scleroderma	0.000634	0.00151	CcSEcCtD
Tolvaptan—Diarrhoea—Leflunomide—systemic scleroderma	0.000634	0.00151	CcSEcCtD
Tolvaptan—Body temperature increased—Lisinopril—systemic scleroderma	0.00063	0.0015	CcSEcCtD
Tolvaptan—Pruritus—Mycophenolic acid—systemic scleroderma	0.000625	0.00149	CcSEcCtD
Tolvaptan—Headache—Azathioprine—systemic scleroderma	0.000615	0.00147	CcSEcCtD
Tolvaptan—Dizziness—Leflunomide—systemic scleroderma	0.000613	0.00146	CcSEcCtD
Tolvaptan—Renal failure—Methotrexate—systemic scleroderma	0.000609	0.00145	CcSEcCtD
Tolvaptan—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000607	0.00145	CcSEcCtD
Tolvaptan—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000605	0.00144	CcSEcCtD
Tolvaptan—Angiopathy—Prednisone—systemic scleroderma	0.000604	0.00144	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000602	0.00144	CcSEcCtD
Tolvaptan—Immune system disorder—Prednisone—systemic scleroderma	0.000601	0.00144	CcSEcCtD
Tolvaptan—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000597	0.00142	CcSEcCtD
Tolvaptan—Hypersensitivity—Lisinopril—systemic scleroderma	0.000587	0.0014	CcSEcCtD
Tolvaptan—Dizziness—Mycophenolic acid—systemic scleroderma	0.000585	0.0014	CcSEcCtD
Tolvaptan—Nausea—Azathioprine—systemic scleroderma	0.000583	0.00139	CcSEcCtD
Tolvaptan—Headache—Leflunomide—systemic scleroderma	0.000581	0.00139	CcSEcCtD
Tolvaptan—Malnutrition—Prednisone—systemic scleroderma	0.000579	0.00138	CcSEcCtD
Tolvaptan—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000575	0.00137	CcSEcCtD
Tolvaptan—Asthenia—Lisinopril—systemic scleroderma	0.000571	0.00136	CcSEcCtD
Tolvaptan—Pruritus—Lisinopril—systemic scleroderma	0.000563	0.00134	CcSEcCtD
Tolvaptan—Headache—Mycophenolic acid—systemic scleroderma	0.000554	0.00132	CcSEcCtD
Tolvaptan—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000552	0.00132	CcSEcCtD
Tolvaptan—Nausea—Leflunomide—systemic scleroderma	0.00055	0.00131	CcSEcCtD
Tolvaptan—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000549	0.00131	CcSEcCtD
Tolvaptan—Urethral disorder—Methotrexate—systemic scleroderma	0.000545	0.0013	CcSEcCtD
Tolvaptan—Diarrhoea—Lisinopril—systemic scleroderma	0.000545	0.0013	CcSEcCtD
Tolvaptan—Ill-defined disorder—Prednisone—systemic scleroderma	0.000538	0.00128	CcSEcCtD
Tolvaptan—Dizziness—Lisinopril—systemic scleroderma	0.000527	0.00126	CcSEcCtD
Tolvaptan—Nausea—Mycophenolic acid—systemic scleroderma	0.000525	0.00125	CcSEcCtD
Tolvaptan—Malaise—Prednisone—systemic scleroderma	0.000523	0.00125	CcSEcCtD
Tolvaptan—Syncope—Prednisone—systemic scleroderma	0.00052	0.00124	CcSEcCtD
Tolvaptan—Cardiac disorder—Methotrexate—systemic scleroderma	0.000516	0.00123	CcSEcCtD
Tolvaptan—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000514	0.00123	CcSEcCtD
Tolvaptan—Loss of consciousness—Prednisone—systemic scleroderma	0.000509	0.00122	CcSEcCtD
Tolvaptan—Angiopathy—Methotrexate—systemic scleroderma	0.000505	0.0012	CcSEcCtD
Tolvaptan—Immune system disorder—Methotrexate—systemic scleroderma	0.000503	0.0012	CcSEcCtD
Tolvaptan—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000501	0.0012	CcSEcCtD
Tolvaptan—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000501	0.00119	CcSEcCtD
Tolvaptan—Headache—Lisinopril—systemic scleroderma	0.000499	0.00119	CcSEcCtD
Tolvaptan—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000494	0.00118	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00049	0.00117	CcSEcCtD
Tolvaptan—Discomfort—Prednisone—systemic scleroderma	0.000487	0.00116	CcSEcCtD
Tolvaptan—Malnutrition—Methotrexate—systemic scleroderma	0.000484	0.00116	CcSEcCtD
Tolvaptan—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000477	0.00114	CcSEcCtD
Tolvaptan—Dysgeusia—Methotrexate—systemic scleroderma	0.000474	0.00113	CcSEcCtD
Tolvaptan—Nausea—Lisinopril—systemic scleroderma	0.000473	0.00113	CcSEcCtD
Tolvaptan—Anaphylactic shock—Prednisone—systemic scleroderma	0.000473	0.00113	CcSEcCtD
Tolvaptan—Shock—Prednisone—systemic scleroderma	0.000465	0.00111	CcSEcCtD
Tolvaptan—Nervous system disorder—Prednisone—systemic scleroderma	0.000464	0.00111	CcSEcCtD
Tolvaptan—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000461	0.0011	CcSEcCtD
Tolvaptan—Skin disorder—Prednisone—systemic scleroderma	0.000459	0.0011	CcSEcCtD
Tolvaptan—Anorexia—Prednisone—systemic scleroderma	0.000451	0.00108	CcSEcCtD
Tolvaptan—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000449	0.00107	CcSEcCtD
Tolvaptan—Headache—Mycophenolate mofetil—systemic scleroderma	0.000437	0.00104	CcSEcCtD
Tolvaptan—Malaise—Methotrexate—systemic scleroderma	0.000437	0.00104	CcSEcCtD
Tolvaptan—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000414	0.000989	CcSEcCtD
Tolvaptan—Decreased appetite—Prednisone—systemic scleroderma	0.000411	0.000981	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000409	0.000977	CcSEcCtD
Tolvaptan—Discomfort—Methotrexate—systemic scleroderma	0.000407	0.000972	CcSEcCtD
Tolvaptan—Constipation—Prednisone—systemic scleroderma	0.000404	0.000965	CcSEcCtD
Tolvaptan—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000395	0.000943	CcSEcCtD
Tolvaptan—Feeling abnormal—Prednisone—systemic scleroderma	0.00039	0.00093	CcSEcCtD
Tolvaptan—Nervous system disorder—Methotrexate—systemic scleroderma	0.000388	0.000925	CcSEcCtD
Tolvaptan—Skin disorder—Methotrexate—systemic scleroderma	0.000384	0.000916	CcSEcCtD
Tolvaptan—Anorexia—Methotrexate—systemic scleroderma	0.000377	0.000899	CcSEcCtD
Tolvaptan—Body temperature increased—Prednisone—systemic scleroderma	0.000374	0.000892	CcSEcCtD
Tolvaptan—Hypersensitivity—Prednisone—systemic scleroderma	0.000348	0.000832	CcSEcCtD
Tolvaptan—Decreased appetite—Methotrexate—systemic scleroderma	0.000344	0.00082	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000341	0.000814	CcSEcCtD
Tolvaptan—Asthenia—Prednisone—systemic scleroderma	0.000339	0.00081	CcSEcCtD
Tolvaptan—Pruritus—Prednisone—systemic scleroderma	0.000335	0.000799	CcSEcCtD
Tolvaptan—Feeling abnormal—Methotrexate—systemic scleroderma	0.000326	0.000777	CcSEcCtD
Tolvaptan—Diarrhoea—Prednisone—systemic scleroderma	0.000324	0.000772	CcSEcCtD
Tolvaptan—Dizziness—Prednisone—systemic scleroderma	0.000313	0.000746	CcSEcCtD
Tolvaptan—Body temperature increased—Methotrexate—systemic scleroderma	0.000312	0.000746	CcSEcCtD
Tolvaptan—Headache—Prednisone—systemic scleroderma	0.000296	0.000707	CcSEcCtD
Tolvaptan—Hypersensitivity—Methotrexate—systemic scleroderma	0.000291	0.000695	CcSEcCtD
Tolvaptan—Asthenia—Methotrexate—systemic scleroderma	0.000284	0.000677	CcSEcCtD
Tolvaptan—Nausea—Prednisone—systemic scleroderma	0.000281	0.00067	CcSEcCtD
Tolvaptan—Pruritus—Methotrexate—systemic scleroderma	0.00028	0.000667	CcSEcCtD
Tolvaptan—Diarrhoea—Methotrexate—systemic scleroderma	0.00027	0.000645	CcSEcCtD
Tolvaptan—Dizziness—Methotrexate—systemic scleroderma	0.000261	0.000624	CcSEcCtD
Tolvaptan—Headache—Methotrexate—systemic scleroderma	0.000248	0.000591	CcSEcCtD
Tolvaptan—Nausea—Methotrexate—systemic scleroderma	0.000235	0.00056	CcSEcCtD
